Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Medical Care Technologies Inc. (OTCID:MDCE) Melanoma Scan Beta Seeks First Volunteer Cohorts for Human-Submitted Image Dataset Testing

$MDCEPress releaseAug 31, 2026, 8:47 AM ETRead the release

Medical Care Technologies announced the start of volunteer recruitment for its MDCE Melanoma Scan Beta platform, marking a transition from public datasets to real-world user-submitted image testing. The initiative aims to evaluate AI performance against variables like lighting, device type, and skin tone, described by CEO Marshall Perkins as a major step beyond established public archives.

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    MDCE: Medical Care Technologies Inc. (OTCID:MDCE) Melanoma Scan Beta Seeks First Volunteer Cohorts for Human-Submitted Image Dataset Testing — AI Analysis | Signal8